Amarin Corporation plc
AMRNNASDAQHealthcare● Active
$13.93
+$0.13(+0.94%)
Market Cap$288111042
P/E Ratio—
52W High$20.9
52W Low$11.65
Amarin Corporation plc (AMRN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AMRN · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 29, 2026EPS Actual
-$0.09
Est. $0.01 · -1000.0%
Revenue
$0.05B
Est. $0.04B · +3.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 29, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
AMRN reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.49B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.49B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 29, 2026 | -$0.01 | — | — | — | $0.04B | — |
| ▼ Q2 FY2026 | Apr 29, 2026 | $0.01 | -$0.09 | -1000.0% | $0.05B | $0.04B | +3.1% |
| ▼ Q1 FY2026 | Feb 25, 2026 | $0.07 | $0.01 | -85.7% | $0.05B | $0.05B | -2.8% |
| ▼ Q4 FY2025 | Oct 29, 2025 | $0.08 | $0.01 | -87.5% | $0.05B | $0.05B | -4.1% |
| ▲ Q3 FY2025 | Jul 30, 2025 | -$0.66 | -$0.03 | +95.5% | $0.05B | $0.04B | +10.9% |
| ▲ Q2 FY2025 | May 7, 2025 | -$1.12 | -$0.04 | +96.4% | $0.04B | $0.05B | -7.2% |
| ▼ Q1 FY2025 | Mar 12, 2025 | -$1.20 | -$2.40 | -100.0% | $0.06B | $0.05B | +22.8% |
| — Q4 FY2024 | Oct 30, 2024 | -$1.00 | -$1.00 | +0.0% | $0.04B | $0.03B | +33.5% |
Q3 FY2026
Jul 29, 2026
EPS Actual
—
EPS Est.
-$0.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 29, 2026Miss
EPS Actual
-$0.09
EPS Est.
$0.01
EPS Surpr.
-1000.0%
Revenue
$0.05B
Q1 FY2026
Feb 25, 2026Miss
EPS Actual
$0.01
EPS Est.
$0.07
EPS Surpr.
-85.7%
Revenue
$0.05B
Q4 FY2025
Oct 29, 2025Miss
EPS Actual
$0.01
EPS Est.
$0.08
EPS Surpr.
-87.5%
Revenue
$0.05B
Q3 FY2025
Jul 30, 2025Beat
EPS Actual
-$0.03
EPS Est.
-$0.66
EPS Surpr.
+95.5%
Revenue
$0.05B
Q2 FY2025
May 7, 2025Beat
EPS Actual
-$0.04
EPS Est.
-$1.12
EPS Surpr.
+96.4%
Revenue
$0.04B
Q1 FY2025
Mar 12, 2025Miss
EPS Actual
-$2.40
EPS Est.
-$1.20
EPS Surpr.
-100.0%
Revenue
$0.06B
Q4 FY2024
Oct 30, 2024
EPS Actual
-$1.00
EPS Est.
-$1.00
EPS Surpr.
+0.0%
Revenue
$0.04B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q4 FY2026 | $0.00 | $0.01 | $0.01 | 1 |
| Q3 FY2026 | $-0.01 | $-0.01 | $-0.00 | 1 |
| Q2 FY2026 | $-0.02 | $-0.01 | $-0.01 | 1 |
| Q1 FY2026 | $-0.01 | $0.01 | $0.03 | 1 |
| Q4 FY2025 | $-0.01 | $0.03 | $0.07 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q4 FY2025 | $0.1B | $0.1B | $0.1B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | Apr 29, 2026 | -1000.0% | $13.96 | $14.29 | +2.36% |
| ▼ Q1 FY2026 | Feb 25, 2026 | -85.7% | $15.52 | $14.05 | -9.47% |
| ▼ Q4 FY2025 | Oct 29, 2025 | -87.5% | $18.94 | $16.81 | -11.25% |
| ▲ Q3 FY2025 | Jul 30, 2025 | +95.5% | $14.65 | $14.97 | +2.18% |
| ▲ Q2 FY2025 | May 7, 2025 | +96.4% | $10.19 | $10.18 | -0.10% |
| ▼ Q1 FY2025 | Mar 12, 2025 | -100.0% | $9.41 | $8.00 | -14.98% |
| ▲ Q4 FY2024 | Oct 30, 2024 | +0.0% | $12.24 | $12.04 | -1.63% |
| ▲ Q3 FY2024 | Jul 31, 2024 | +100.0% | $15.65 | $13.64 | -12.84% |
Q2 FY2026+2.36%
Report Date
Apr 29, 2026
EPS Beat/Miss
-1000.0%
Price Before
$13.96
Price After
$14.29
Q1 FY2026-9.47%
Report Date
Feb 25, 2026
EPS Beat/Miss
-85.7%
Price Before
$15.52
Price After
$14.05
Q4 FY2025-11.25%
Report Date
Oct 29, 2025
EPS Beat/Miss
-87.5%
Price Before
$18.94
Price After
$16.81
Q3 FY2025+2.18%
Report Date
Jul 30, 2025
EPS Beat/Miss
+95.5%
Price Before
$14.65
Price After
$14.97
Q2 FY2025-0.10%
Report Date
May 7, 2025
EPS Beat/Miss
+96.4%
Price Before
$10.19
Price After
$10.18
Q1 FY2025-14.98%
Report Date
Mar 12, 2025
EPS Beat/Miss
-100.0%
Price Before
$9.41
Price After
$8.00
Q4 FY2024-1.63%
Report Date
Oct 30, 2024
EPS Beat/Miss
+0.0%
Price Before
$12.24
Price After
$12.04
Q3 FY2024-12.84%
Report Date
Jul 31, 2024
EPS Beat/Miss
+100.0%
Price Before
$15.65
Price After
$13.64
Avg Beat Reaction-3.10%
Avg Miss Reaction-8.34%
Beat Rate4 / 8 quarters
Largest Move-14.98% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AMRN ends December
Amarin Corporation plc (AMRN) most recently reported earnings on April 29, 2026 for Q2 FY2026, posting EPS of $-0.09 — missing the analyst consensus of $0.01 by -1000.0%. The next AMRN earnings date is expected around September 1, 2026.
Each quarter, investors track AMRN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AMRN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AMRN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AMRN earnings · 5 questionsAmarin Corporation plc's next earnings report is expected around September 1, 2026. AMRN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AMRN historically reports after market close (AMC).
AMRN earnings datewhen is AMRN earningsAMRN next earnings datewhen does AMRN report earningsAMRN earnings calendar
▸ Source: FMP · Amarin Corporation plc SEC filings · US GAAP · Amarin Corporation plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026